Literature DB >> 7688547

Suppression of anchorage-independent growth after gene transfection.

D J Winterbourne1, S Thomas, J Hermon-Taylor.   

Abstract

A novel procedure for isolating anchorage-dependent cells has been developed. It involves negative selection of cells growing in suspension followed by clonal replica screening for anchorage-dependent growth. Cells which have regained anchorage-dependent growth have been isolated from a library of the Chinese hamster ovary cell line, CHO-K1, transfected with pSV2neo and human genomic DNA. One anchorage-dependent clone, 1042AC, has been studied in detail. Anchorage-dependent growth of 1042AC is stable when cultured as adherent monolayers, but revertants appear rapidly when cultured in suspension. Suppression is unlikely to be due to loss or mutation of hamster genes conferring anchorage-independent growth as hybrids between 1042AC and CHO-K1 have the suppressed phenotype of 1042AC. Furthermore, a population of cells obtained from the hybrid by selecting for revertants to anchorage-independent growth showed selective loss of the transgenome derived from 1042AC. The growth suppression was not due to transfection of the human Krev-1 gene, which has previously been shown to restore anchorage-dependent growth, nor was there any evidence of alteration in the endogenous hamster Krev-1 gene. However, evidence for a human gene being responsible for the suppressed phenotype has not been obtained yet.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688547      PMCID: PMC1968545          DOI: 10.1038/bjc.1993.323

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Expressed genes, Alu repeats and polymorphisms in cosmids sequenced from chromosome 4p16.3.

Authors:  W R McCombie; A Martin-Gallardo; J D Gocayne; M FitzGerald; M Dubnick; J M Kelley; L Castilla; L I Liu; S Wallace; S Trapp
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

Review 3.  Expression cloning of tumor suppressor genes: a guide for optimists.

Authors:  M Noda
Journal:  Mol Carcinog       Date:  1990       Impact factor: 4.784

4.  Evidence for human DNA-mediated transfer of the suppressed phenotype into malignant Chinese hamster cells.

Authors:  R Schäfer; A C Nirkko; P M Ambühl; K H Grzeschik; I Schwarte-Waldhoff
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

5.  Anchorage and growth regulation in normal and virus-transformed cells.

Authors:  M Stoker; C O'Neill; S Berryman; V Waxman
Journal:  Int J Cancer       Date:  1968-09-15       Impact factor: 7.396

6.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

7.  Fte-1, a v-fos transformation effector gene, encodes the mammalian homologue of a yeast gene involved in protein import into mitochondria.

Authors:  C J Kho; H Zarbl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells.

Authors:  S A Madreperla; J A Whittum-Hudson; R A Prendergast; P L Chen; W H Lee
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

9.  Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3':5'-monophosphate and testosterone.

Authors:  A W Hsie; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  Suppression of the chemically transformed phenotype of BHK cells by a human cDNA.

Authors:  M V Eiden; L MacArthur; H Okayama
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.